HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bharat B Aggarwal Selected Research

Curcumin

9/2019Is curcumin bioavailability a problem in humans: lessons from clinical trials.
11/2018Dietary nutraceuticals as backbone for bone health.
8/2017Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
1/2017Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.
1/2017Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric.
8/2016Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention.
12/2015Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
12/2014Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses.
11/2014Curcumin, a component of golden spice: from bedside to bench and back.
1/2014Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-α-induced NF-κB activation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bharat B Aggarwal Research Topics

Disease

265Neoplasms (Cancer)
01/2021 - 01/2002
69Inflammation (Inflammations)
11/2021 - 03/2002
67Neoplasm Metastasis (Metastasis)
12/2019 - 09/2002
53Carcinogenesis
01/2021 - 09/2002
27Multiple Myeloma
12/2015 - 02/2003
25Breast Neoplasms (Breast Cancer)
08/2016 - 09/2002
24Chronic Disease (Chronic Diseases)
11/2021 - 01/2007
20Pancreatic Neoplasms (Pancreatic Cancer)
03/2016 - 11/2004
19Leukemia
12/2015 - 08/2003
17Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2008
13Colonic Neoplasms (Colon Cancer)
01/2016 - 02/2006
12Rheumatoid Arthritis
01/2020 - 09/2003
12Prostatic Neoplasms (Prostate Cancer)
01/2013 - 12/2002
11Arthritis (Polyarthritis)
01/2009 - 07/2004
10Osteoporosis
11/2018 - 12/2004
10Obesity
01/2018 - 11/2004
9Bone Resorption
02/2012 - 09/2003
8Asthma (Bronchial Asthma)
01/2020 - 07/2004
8Cardiovascular Diseases (Cardiovascular Disease)
09/2019 - 11/2005
8Psoriasis (Pustulosis Palmaris et Plantaris)
10/2014 - 12/2004
8Carcinoma (Carcinomatosis)
01/2011 - 09/2004
7Hypoxia (Hypoxemia)
01/2018 - 07/2002
7Acquired Immunodeficiency Syndrome (AIDS)
07/2011 - 01/2003
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2011 - 01/2002
7Melanoma (Melanoma, Malignant)
10/2010 - 09/2004
7Atherosclerosis
02/2008 - 07/2004
6Lung Neoplasms (Lung Cancer)
12/2015 - 12/2006
6Crohn Disease (Crohn's Disease)
10/2014 - 12/2004
6Myeloid Leukemia (Leukemia, Myelocytic)
08/2010 - 12/2002
6Alzheimer Disease (Alzheimer's Disease)
02/2008 - 12/2004
5Metabolic Diseases (Metabolic Disease)
09/2019 - 02/2009
5Autoimmune Diseases (Autoimmune Disease)
01/2017 - 04/2007
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2013 - 12/2002

Drug/Important Bio-Agent (IBA)

129NF-kappa B (NF-kB)IBA
01/2018 - 03/2002
72CurcuminIBA
09/2019 - 01/2002
69Transcription Factors (Transcription Factor)IBA
01/2021 - 08/2002
54Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2002
38Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 02/2002
36Cyclin D1IBA
01/2017 - 12/2002
31Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 11/2004
29CytokinesIBA
11/2021 - 09/2003
24Pharmaceutical PreparationsIBA
01/2019 - 04/2004
18LigandsIBA
03/2016 - 09/2003
16ResveratrolIBA
03/2019 - 09/2002
15Phosphotransferases (Kinase)IBA
01/2016 - 08/2004
14SurvivinIBA
01/2017 - 11/2004
14Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2014 - 09/2002
13Biomarkers (Surrogate Marker)IBA
03/2020 - 06/2006
12DNA (Deoxyribonucleic Acid)IBA
12/2019 - 04/2004
12GemcitabineFDA Link
03/2016 - 11/2004
12TriterpenesIBA
08/2013 - 08/2003
12CarcinogensIBA
01/2012 - 09/2002
12I-kappa B KinaseIBA
11/2010 - 02/2003
10Death Domain ReceptorsIBA
01/2016 - 08/2009
9Matrix Metalloproteinases (MMPs)IBA
01/2021 - 11/2004
9Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2018 - 12/2002
9Interleukin-6 (Interleukin 6)IBA
01/2016 - 10/2003
9EsterasesIBA
12/2015 - 07/2008
9CaspasesIBA
08/2013 - 09/2004
8AntioxidantsIBA
11/2021 - 01/2007
8PolyphenolsIBA
12/2019 - 01/2003
8zerumboneIBA
11/2018 - 10/2005
8Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2018 - 07/2004
8EnzymesIBA
01/2014 - 11/2004
8Thalidomide (Thalomid)FDA Link
04/2013 - 03/2002
8Bortezomib (Velcade)FDA Link
04/2013 - 05/2004
8SmokeIBA
11/2009 - 09/2002
7STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2018 - 05/2007
7Anti-Inflammatory Agents (Anti-Inflammatories)IBA
08/2016 - 01/2006
7Biological ProductsIBA
02/2016 - 11/2004
7Cysteine (L-Cysteine)FDA Link
01/2016 - 01/2009
7TocotrienolsIBA
01/2016 - 08/2010
7Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2013 - 07/2004
7Paclitaxel (Taxol)FDA LinkGeneric
03/2012 - 10/2005
7PhosphatidylserinesIBA
02/2012 - 01/2009
6celastrolIBA
02/2019 - 04/2007
6Protein Kinases (Protein Kinase)IBA
10/2017 - 08/2005
6Reactive Oxygen Species (Oxygen Radicals)IBA
08/2016 - 08/2009
6TNF-Related Apoptosis-Inducing LigandIBA
10/2014 - 02/2002
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 11/2004
6Caspase 8 (Caspase-8)IBA
02/2012 - 09/2009
6PhytochemicalsIBA
06/2010 - 07/2003
5Lymphotoxin-alpha (Lymphotoxin)IBA
01/2021 - 01/2012
5calebin-AIBA
01/2021 - 10/2017
5Therapeutic UsesIBA
01/2019 - 09/2004
5gambogic acidIBA
11/2018 - 03/2008
5plumbaginIBA
11/2018 - 06/2006
5buteinIBA
11/2018 - 06/2007
5Environmental Pollutants (Pollutants, Environmental)IBA
01/2018 - 09/2008
5InterleukinsIBA
01/2018 - 03/2006
5Ursolic AcidIBA
03/2016 - 08/2003
5ChemokinesIBA
01/2016 - 01/2003
5Antineoplastic Agents (Antineoplastics)IBA
10/2014 - 01/2002
5Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
05/2012 - 01/2006
5Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
11/2011 - 01/2006

Therapy/Procedure

56Therapeutics
01/2018 - 07/2002
16Drug Therapy (Chemotherapy)
01/2018 - 11/2003
7Traditional Medicine (Folk Remedies)
07/2014 - 01/2006
7Radiotherapy
12/2012 - 11/2005
6Chemoprevention
06/2010 - 09/2002